🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to compare the rate and extent of absorption o...
Status
Completed
Location
Anaphann Inc.
Start Date
2003-01
Trial ID
NCT01149954
Treatments Being Tested
To compare the rate and extent of absorption of griseofulvin from a test fo...
Status
Completed
Location
Biovail Contract Research (A Division of Biovail Corporation)
Start Date
2005-11
Trial ID
NCT00864071
This study will assess the safety, tolerability, and efficacy of dapsone in...
Status
Withdrawn
Location
Multiple Locations
Start Date
2013-03
Trial ID
NCT01785836
Treatments Being Tested
The purpose of this study is to determine whether ETBX-021 is safe and effe...
Status
Terminated
Location
Chan Soon-Shiong Institute for Medicine
Start Date
2017-03-04
Trial ID
NCT02751528
Treatments Being Tested
The purpose of the study is to assess the oral bioavailability of the two t...
Status
Withdrawn
Location
Multiple Locations
Start Date
2016-11-22
Trial ID
NCT02951845
Open-Label study evaluating safety and efficacy of SM-020 Gel 1.0% in subje...
Status
Unknown
Location
Dermatology, Laser and Vein Specialist
Start Date
2024-03-25
Trial ID
NCT06409195
Treatments Being Tested
The purpose of this study is to evaluate the quality criteria of the SLN de...
Status
Completed
Location
Centre Paul Papin
Start Date
2008-03
Trial ID
NCT00636467
Treatments Being Tested
The purpose of this study is to verify that an infusion of hypertonic salin...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT01438502
Treatments Being Tested
This is a two-arm, open-label study that aims to compare the incidence and ...
Status
Completed
Location
Rochester Skin Lymphoma Medical Group, PLLC
Start Date
2017-12-13
Trial ID
NCT03380026
Treatments Being Tested
This study will be a single-center, single blind, randomized controlled tri...
Status
Completed
Location
UnityPoint Health-Meriter Hospital
Start Date
2019-02-15
Trial ID
NCT03810235
Treatments Being Tested